Table 2.

Variables associated with tumor upgrading in the low-risk population (n=170)

Variables	Tumor upgrading on the surgical specimen		p
	No (n = 59)	Yes (n= 111)
Age, median (range)	63.3 (52–57)	65.0 (46–75)	0.297
BMI, median (range)	26.1 (20–34)	26.4 (20–42)	0.136
PSA, median (range)	5.5 (0.75–9.69)	6.05 (2.42–9.92)	0.021
PV, median (range)	40.0 (16–120)	39.0 (15–110)	0.038
P+, median (range)	0.17 (0.05–0.60)	0.29 (0.06–0.78)	0.004
V+, median (range)	5.0 (2.0–70.0)	15.0 (2.0–70.0)	< 0.0001
W, median (range)	53.0 (30–130)	50.0 (23–129)	0.196
cT			0.141
1c, n (%)	55 (36.7)	95 (63.3)
2a, n (%)	4 (20)	16 (80)	0.036
pT
= 2	56 (37.6)	93 (62.4)
> 2	3 (14.3)	18 (85.7)

PV = Prostate volume; P+ = proportion of biopsy positive cores; V+ = percentage of cancer related to volume of the prostate; W = prostate weight; cT = clinical tumor stage; pT = pathological tumor stage.